Testing
Industry Insight
Pharmaceutical Testing in Pakistan: What Manufacturers Outsource
Which pharma tests Pakistani manufacturers outsource, the ICH, WHO and FDA limits behind them, worked examples, and how to check a contract laboratory.

Pakistani manufacturers keep routine identity, assay and physical tests in house and send out the work that needs an expensive instrument or a separate facility: elemental impurities, residual solvents, nitrosamines, stability studies, method validation and microbiology.
Two checks decide whether outsourced results will stand up. The laboratory's accreditation scope must name the method, not just the standard ISO/IEC 17025. And the buyer or auditor should know the published limit before reading the report, because each of these tests answers to a specific number in an ICH, WHO or FDA document.
What gets outsourced, and why
Test family | Principal instrument | Why it leaves the site |
|---|---|---|
Method development and validation | HPLC, LC-MS/MS, GC-MS | Needs method expertise and validation records, not just an instrument |
Stability studies, accelerated and long term | Stability chambers plus the analytical suite | Ties up chamber space for the whole study, often two years or more |
Elemental impurities | ICP-MS, ICP-OES | High capital cost and demanding sample preparation for an occasional test |
Residual solvents | Headspace GC-MS | Headspace capability is expensive and the test is episodic |
Nitrosamines | LC-MS/MS | Limits are set in nanograms per day, so the method has to reach trace levels |
DEG and EG in glycerin, propylene glycol and sorbitol | GC | Required on incoming lots, not just once |
Microbiology, sterility and endotoxin | Classified clean areas, incubators, LAL | A separate facility and discipline from a chemistry laboratory |
Routine identity, assay and physical testing usually stays in house, because the volume justifies the equipment and release needs a fast turnaround. The outsourcing decision is a fixed cost against a variable one: an instrument costs money whether or not there is work for it.
Accreditation adds a second cost. Under ISO/IEC 17025 a laboratory is accredited for specific methods, so a manufacturer that brings a test in house for two runs a year also takes on its scope assessment and proficiency testing. A test report can only support what its method scope covers.
The published limits behind each test
Know the number before the report arrives. These are the limits the main outsourced tests answer to, from the source documents:
Test | Source | Published limit or requirement |
|---|---|---|
Elemental impurities | Class 1 oral PDEs: Cd 5, Pb 5, As 15, Hg 30 µg/day. For a product taken at no more than 10 g a day (Option 1): Cd 0.5, Pb 0.5, As 1.5, Hg 3 µg/g | |
Residual solvents | Class 1 to be avoided (benzene 2 ppm). Class 2 limited (methanol 3,000 ppm). Class 3: 50 mg a day or less, 5,000 ppm under Option 1, acceptable without justification | |
Nitrosamines | NDMA about 96 ng/day. Where no limit can be derived, FDA recommends 26.5 ng/day | |
DEG and EG in high-risk excipients | Not more than 0.10%, tested on representative samples of each shipment of each lot before use | |
Bacterial endotoxin, medical devices | 0.5 EU/mL or 20 EU/device for cardiovascular and lymphatic contact; 0.06 EU/mL or 2.15 EU/device for cerebrospinal fluid contact | |
Stability, long term | 25 °C/60% RH or 30 °C/65% RH, at least 12 months of data at submission. Pakistan's confirmed condition: 30 °C/65% RH |
The DEG and EG requirement is not paperwork. The FDA guidance links contaminated syrups to more than 300 deaths, mostly children under 5, in at least seven countries, and notes that in Oct 2022 Indonesian authorities found DEG and EG in a propylene glycol excipient.
Worked examples: turning a limit into a specification
Elemental impurities. ICH Q3D converts a daily limit into a concentration: permitted µg/g = PDE in µg/day ÷ daily intake of the drug product in g/day. For a product taken at 2 g a day, lead at 5 µg/day allows 2.5 µg/g in each component (Option 2a), five times the 0.5 µg/g that Option 1 assumes for a 10 g daily dose.
Nitrosamines. FDA's conversion is ppm = acceptable intake in ng/day ÷ maximum daily dose in mg. For a drug with a maximum daily dose of 320 mg, NDMA at 96 ng/day becomes a limit of 0.3 ppm. Ask the laboratory for its quantitation limit before testing: a method that cannot see 0.3 ppm cannot pass the batch.
Stability. For a 24-month shelf life, ICH Q1A(R2) recommends long-term testing every 3 months in the first year, every 6 months in the second and annually after that, and at least three time points (0, 3 and 6 months) at the accelerated condition of 40 °C/75% RH. On three primary batches that is:
Long term at 30 °C/65% RH: 7 time points (0, 3, 6, 9, 12, 18, 24 months) × 3 batches = 21 pulls.
Accelerated at 40 °C/75% RH: 3 time points × 3 batches = 9 pulls.
Total: 30 full test sets, with chamber space held for two years. That is the capacity a contract laboratory has to commit.
WHO's table of stability conditions (update of Mar 2021) lists Pakistan's confirmed long-term condition as 30 °C/65% RH, so a product registered for Pakistan should be studied there, not at 25 °C/60% RH. Export markets set their own condition; confirm it with each importing regulator before samples go into the chamber.
A contract laboratory tests and reports; it does not release the batch
A contract testing laboratory and a contract manufacturing organisation are often confused, and the confusion leaves a gap in accountability. A contract testing laboratory tests samples the client supplies and reports results. It does not release product and takes no responsibility for the manufacturing process. A contract manufacturing organisation makes the product under the client's licence and carries manufacturing responsibility for it.
So put the appointment in writing: what is tested, by which method, and who releases the batch. In Pakistan the regulator is the Drug Regulatory Authority of Pakistan; international procurement often turns on WHO prequalification and on inspection regimes aligned to PIC/S. Each expects a named party to be accountable for release.
Check a contract laboratory on six points
Accreditation scope for the method and matrix. "ISO 17025 accredited" is not enough. Accreditation for one assay does not cover another that runs on the same instrument.
Method transfer records. When a method moves between laboratories, the transfer is documented, not assumed.
Data integrity controls. Instrument audit trails switched on, controlled access to the chromatography data system, individual logins only.
Proficiency testing for the relevant methods, with the latest round and its outcome available on request.
Sample chain of custody from receipt through storage to disposal, with storage conditions recorded.
Audit rights written into the agreement.
Then ask: which methods on the scope cover the work being sent? A laboratory should answer from its scope document, not from memory.
What the report has to show
Element | Why it matters |
|---|---|
Method reference with year or version | A method without a version cannot be reproduced or defended |
Accreditation statement with certificate number | Connects the result to an assessed scope |
Result, limit and pass or fail per parameter | Allows review rather than interpretation |
Limit of quantitation | Shows the method could see the limit at all |
Measurement uncertainty, where applicable | A result near a limit cannot be decided without it |
Sample identification matching the batch record | Prevents a result being attached to the wrong batch |
Authorised signatory with name and role | Establishes who is accountable for the result |
A date sequence from receipt to report that makes sense | An impossible sequence is the first sign of a documentation problem |
For nutraceuticals and herbal products the same logic applies to identity, potency and contaminants: label-claim verification, heavy metals and pesticide residues carry the commercial risk.
Where Tti Labs fits
ISO/IEC 17025 testing under PNAC LAB-022. Its pharma section lists microbial enumeration and specified organisms (USP <61> and <62>), sterility (USP <71>), endotoxin (USP <85> and <161>), NDMA and NDEA by FDA methods, and DEG and EG in propylene glycol, glycerin and sorbitol to the USP-NF monographs.
Wider pharmaceutical services for raw materials, APIs, excipients and finished dosage forms: assay and purity, impurities including residual solvents and elemental impurities, stability and shelf-life studies, method development and validation to ICH quality guidelines and pharmacopoeial requirements, extractables and leachables, and container closure integrity.
Instruments: HPLC with UV/Vis, DAD and MS/MS detection, LC-MS/MS, single and triple quadrupole systems, GC-FID, GC-MS, headspace GC-MS, AAS, ICP-OES, ICP-MS, UV/Vis, FTIR and ELISA kits.
A US IAC certified microbiology laboratory with ISO Class 5 and Class 7 areas, for sterility, endotoxin (LAL), bioburden, preservative efficacy and environmental monitoring.
Nutraceutical and herbal testing: vitamins and minerals, fatty acid and nutritional profiles, heavy metals, pesticide residues and herbal extracts.
For any method not named in the LAB-022 pharma section, ask whether the result will be issued under accreditation before sending samples. Tti Labs tests samples and reports results. It does not release batches, act as a contract manufacturer or grant marketing authorisation.
Discuss pharmaceutical testing with Tti Labs or contact the laboratory. UAN 111 786 001. ISO/IEC 17025 accredited through PNAC, LAB-022. US IAC certified microbiology laboratory.
Related guides: Food and Agricultural Export Testing in Pakistan: The Certification Route.
FAQ
Does a laboratory test release a batch?
No. The licence holder releases the batch. Testing produces the evidence behind that decision; the decision stays with the manufacturer.
What should a buyer check first in a contract laboratory?
The accreditation scope for the specific method and matrix. ISO/IEC 17025 accreditation attaches to methods, so a general claim of being accredited says nothing about the test being sent.
What stability condition applies to medicines sold in Pakistan?
WHO's table of stability conditions lists Pakistan's confirmed long-term condition as 30 °C/65% RH. ICH Q1A(R2) pairs it with accelerated testing at 40 °C/75% RH for 6 months.
What is the DEG and EG limit for glycerin and propylene glycol?
Not more than 0.10%, as recognised by the USP-NF monographs. FDA recommends testing representative samples of each shipment of each lot before the component is used.
How is a nitrosamine limit turned into a specification?
Divide the acceptable intake in ng/day by the maximum daily dose in mg to get ppm. NDMA at 96 ng/day in a drug dosed at up to 320 mg a day gives 0.3 ppm.
References
Pharmaceutical testing services, Tti Labs, https://www.ttilabs.net/pharma
Accreditation scope LAB-022 (ISO/IEC 17025:2017, valid to 8 Aug 2027), Pakistan National Accreditation Council, https://pnac.gov.pk/pdfFiles/LAB-022
Q3D(R2) Guideline for elemental impurities (26 Apr 2022), ICH, https://database.ich.org/sites/default/files/Q3D-R2_Guideline_Step4_2022_0308.pdf
ICH Q3C(R9) Guideline for residual solvents (in effect 29 Apr 2024), European Medicines Agency, https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q3c-r9-guideline-impurities-guideline-residual-solvents-step-5_en.pdf
Q1A(R2) Stability testing of new drug substances and products (6 Feb 2003), ICH, https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf
Stability conditions for WHO Member States by Region (update Mar 2021), World Health Organization, https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs953-annex2-appendix1-stability-conditions-table-2018.pdf
Control of nitrosamine impurities in human drugs, Revision 2 (Sep 2024), US Food and Drug Administration, https://www.fda.gov/media/141720/download
Testing of glycerin, propylene glycol and other high-risk drug components for DEG and EG (May 2023), US Food and Drug Administration, https://www.fda.gov/media/167974/download
Pyrogen and endotoxins testing: questions and answers, Edition 2, US Food and Drug Administration, https://www.fda.gov/media/83477/download
ICH quality guidelines, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, https://www.ich.org/page/quality-guidelines
Drug Regulatory Authority of Pakistan, DRAP, https://www.dra.gov.pk/
WHO Prequalification of Medical Products, World Health Organization, https://www.who.int/teams/regulation-prequalification
Pharmaceutical Inspection Co-operation Scheme, PIC/S, https://picscheme.org/
Testing services, Tti Labs, https://www.ttilabs.net/testing
Accreditations, Tti Labs, https://www.ttilabs.net/accreditations
Contact, Tti Labs, https://www.ttilabs.net/contact
Recommended reading

Compliance
PPWR Packaging Rules for Pakistan Exporters

Testing
Fabric Shrinkage Testing: Methods, Calculation and Limits

Testing
GPSR for Pakistani Exporters: What the EU Product Safety Rules Require

Testing
Thread Count and Towel GSM: How Each Is Tested and Labelled
ISO/IEC 17025 ACCREDITED
Testing, inspection and certification for Pakistani exports.
General
PPWR packaging rules for Pakistan exporters: recyclable design, recycled content targets, empty space limits and why the EPR fee falls on the EU importer.
General
Fabric shrinkage testing explained: ISO 5077, ISO 6330 and AATCC 135 and 150, how the percentage is calculated, spirality, and how to set the limit.
General
What the EU GPSR asks of Pakistani exporters: the EU responsible person, labels, technical documentation, online listings, and the tests that back them.











